Showing 1 - 8 results of 8 for search 'Johannes R. Bogner', query time: 0.03s Refine Results
  1. 1
    Atripla™ – HIV therapy in one pill

    Atripla™ – HIV therapy in one pill by Boris Julg, Johannes R Bogner

    Published 2008-06-01
    Get full text
    Article
  2. 2
    Adaptation of CD8 T cell responses to changing HIV-1 sequences in a cohort of HIV-1 infected individuals not selected for a certain HLA allele.

    Adaptation of CD8 T cell responses to changing HIV-1 sequences in a cohort of HIV-1 infected individuals not selected for a certain HLA allele. by Julia Roider, Anna-Lena Kalteis, Thomas Vollbrecht, Lisa Gloning, Renate Stirner, Nadja Henrich, Johannes R Bogner, Rika Draenert

    Published 2013-01-01
    Get full text
    Article
  3. 3
    SERINC5 Is an Unconventional HIV Restriction Factor That Is Upregulated during Myeloid Cell Differentiation

    SERINC5 Is an Unconventional HIV Restriction Factor That Is Upregulated during Myeloid Cell Differentiation by Ariane Zutz, Christian Schölz, Stephanie Schneider, Virginia Pierini, Maximilian Münchhoff, Kathrin Sutter, Georg Wittmann, Ulf Dittmer, Rika Draenert, Johannes R. Bogner, Oliver T. Fackler, Oliver T. Keppler

    Published 2020-01-01
    Get full text
    Article
  4. 4
    High frequencies of PMN-MDSCs are associated with low suppressive capacity in advanced stages of HIV-1 infection

    High frequencies of PMN-MDSCs are associated with low suppressive capacity in advanced stages of HIV-1 infection by Eva M. Grützner, Ashley Neizert, Renate Stirner, Raffaele Conca, Immanuel Andrä, Lisa Wolff, Matthias Schiemann, Lesca M. Holdt, Christoph Klein, Johannes R. Bogner, Rika Draenert

    Published 2020-01-01
    Get full text
    Article
  5. 5
    Overnight resting of PBMC changes functional signatures of antigen specific T- cell responses: impact for immune monitoring within clinical trials.

    Overnight resting of PBMC changes functional signatures of antigen specific T- cell responses: impact for immune monitoring within clinical trials. by Sarah Kutscher, Claudia J Dembek, Simone Deckert, Carolina Russo, Nina Körber, Johannes R Bogner, Fabian Geisler, Andreas Umgelter, Michael Neuenhahn, Julia Albrecht, Antonio Cosma, Ulrike Protzer, Tanja Bauer

    Published 2013-01-01
    Get full text
    Article
  6. 6
    Changes in Cardiovascular Disease Risk Factors With Immediate Versus Deferred Antiretroviral Therapy Initiation Among HIV‐Positive Participants in the START (Strategic Timing of Antiretroviral Treatment) Trial

    Changes in Cardiovascular Disease Risk Factors With Immediate Versus Deferred Antiretroviral Therapy Initiation Among HIV‐Positive Participants in the START (Strategic Timing of An... by Jason V. Baker, Shweta Sharma, Amit C. Achhra, Jose Ignacio Bernardino, Johannes R. Bogner, Daniel Duprez, Sean Emery, Brian Gazzard, Jonathan Gordin, Greg Grandits, Andrew N. Phillips, Siegfried Schwarze, Elsayed Z. Soliman, Stephen A. Spector, Giuseppe Tambussi, Jens Lundgren

    Published 2017-05-01
    Get full text
    Article
  7. 7
    Estimating trends in the proportion of transmitted and acquired HIV drug resistance in a long term observational cohort in Germany.

    Estimating trends in the proportion of transmitted and acquired HIV drug resistance in a long term observational cohort in Germany. by Daniel Schmidt, Christian Kollan, Gerd Fätkenheuer, Eugen Schülter, Hans-Jürgen Stellbrink, Christian Noah, Björn-Erik Ole Jensen, Matthias Stoll, Johannes R Bogner, Josef Eberle, Karolin Meixenberger, Claudia Kücherer, Osamah Hamouda, Barbara Bartmeyer, ClinSurv-HIV Drug Resistance Study Group in CHAIN

    Published 2014-01-01
    Get full text
    Article
  8. 8
    Immediate versus deferred antiretroviral therapy in HIV-infected patients presenting with acute AIDS-defining events (toxoplasmosis, Pneumocystis jirovecii-pneumonia): a prospective, randomized, open-label multicenter study (IDEAL-study)

    Immediate versus deferred antiretroviral therapy in HIV-infected patients presenting with acute AIDS-defining events (toxoplasmosis, Pneumocystis jirovecii-pneumonia): a prospectiv... by Guido Schäfer, Christian Hoffmann, Keikawus Arasteh, Dirk Schürmann, Christoph Stephan, Björn Jensen, Matthias Stoll, Johannes R. Bogner, Gerd Faetkenheuer, Jürgen Rockstroh, Hartwig Klinker, Georg Härter, Albrecht Stöhr, Olaf Degen, Eric Freiwald, Anja Hüfner, Sabine Jordan, Julian Schulze zur Wiesch, Marylyn Addo, Ansgar W. Lohse, Jan van Lunzen, Stefan Schmiedel, the IDEAL study group

    Published 2019-11-01
    Get full text
    Article

Search Tools: